- cafead   Jan 17, 2023 at 11:02: PM
via The top-line readout from COVID-19 vaccine maker Moderna for a respiratory syncytial virus (RSV) vaccine seems to keep pace with leading competitors GSK and Pfizer as the three gear up for what is expected to be a very tight commercial market.
article source
article source